Prot# 32101-2-05: An Open-Label, Treatment Continuation Study of 2% Nanocrystalline Silver Cream (NPI 32101) Applied Twice Daily in Children with Atopic Dermatitis Who Previously Completed a Double-Blind, Placebo-Controlled Study of NPI 32101

Project: Research project

Project Details

StatusFinished
Effective start/end date4/10/06 → 7/31/07

Funding

  • NUCRYST Pharmaceuticals Inc. (32101-2-05)